BioCryst (BCRX) Receives Prelim. Comment Letter from FDA for Peramivir
Go back to BioCryst (BCRX) Receives Prelim. Comment Letter from FDA for PeramivirBioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 5.07 +0.07 (1.40%) | |||||
---|---|---|---|---|---|---|
Previous Close | $5.00 | 52 Week High | $10.98 | |||
Open | $5.00 | 52 Week Low | $1.63 | |||
Day High | $5.18 | P/E | N/A | |||
Day Low | $4.89 | EPS | $-0.68 | |||
Volume | 4,350,738 |